By Zachary Zagger ( January 16, 2015, 1:58 PM EST) -- Baker Botts LLP-guided Depomed Inc. said Thursday it will pay Belgian drugmaker Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, $1.05 billion to acquire the U.S. rights to its Nucynta line of painkillers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.